Satish K Chitneni

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2021
Publications (10 Years): 4

Top Topics

Metastatic Breast Cancer

Capillary Electrophoresis

Epidermal Growth Factor Receptor

Top Venues

Molecular pharmaceutics

Clinical cancer research : an official journal of the American Association for Cancer Research

Pharmaceuticals (Basel, Switzerland)

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Zhengyuan Zhou, Michael R Zalutsky, Satish K Chitneni
Fluorine-18 Labeling of the MDM2 Inhibitor RG7388 for PET Imaging: Chemistry and Preliminary Evaluation. Molecular pharmaceutics 18 (10) (2021)
Satish K Chitneni, Zhengyuan Zhou, Brian E Watts, Michael R Zalutsky
Feasibility of Developing Radiotracers for MDM2: Synthesis and Preliminary Evaluation of an 18F-Labeled Analogue of the MDM2 Inhibitor SP-141. Pharmaceuticals (Basel, Switzerland) 14 (4) (2021)
Satish K Chitneni, Eftychia Koumarianou, Ganesan Vaidyanathan, Michael R Zalutsky
Observations on the Effects of Residualization and Dehalogenation on the Utility of N-Succinimidyl Ester Acylation Agents for Radioiodination of the Internalizing Antibody Trastuzumab. Molecules (Basel, Switzerland) 24 (21) (2019)
Patrick C Gedeon, Teilo H Schaller, Satish K Chitneni, Bryan D Choi, Chien-Tsun Kuan, Carter M Suryadevara, David J Snyder, Robert J Schmittling, Scott E Szafranski, Xiuyu Cui, Patrick N Healy, James E Herndon, Roger E McLendon, Stephen T Keir, Gary E Archer, Elizabeth A Reap, Luis Sanchez-Perez, Darell D Bigner, John H Sampson
A Rationally Designed Fully Human EGFRvIII:CD3-Targeted Bispecific Antibody Redirects Human T Cells to Treat Patient-derived Intracerebral Malignant Glioma. Clinical cancer research : an official journal of the American Association for Cancer Research 24 (15) (2018)